Currently, tumor tissues obtained by surgery or biopsy (including thoracoscopic pleural metastatic tissue biopsy) are commonly used for EGFR mutation test,[5]–[7] but unfortunately, it is difficult to obtain adequate amount of tumor tissues from patients with advanced lung adenocarcinoma. Here, EGFR is linked to lung adenocarcinoma.